New Drug Applications

Visiox Pharma Announces FDA Acceptance of New Drug Application for Glaucoma

Written by David Miller

TARRYTOWN, N.Y., Dec. 8, 2022 /PRNewswire/ — Visiox Pharma, LLC., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic drugs to address highly prevalent diseases in need of new treatment…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]